Dow Up0.10% Nasdaq Down0.00%

Abbott Laboratories (ABT)

-NYSE
42.65 Down 0.15(0.35%) 11:29AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 5,551,000   5,244,000   5,654,941   5,369,059  
Cost of Revenue2,506,000  2,470,000  2,612,895  2,450,105  
Gross Profit 3,045,000   2,774,000   3,042,046   2,918,954  
Operating Expenses
Research Development335,000  387,000  386,243  356,757  
Selling General and Administrative1,788,000  1,762,000  1,701,473  1,734,527  
Non Recurring -   -   -   -  
Others161,000  174,000  197,933  197,067  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 761,000   451,000   756,397   630,603  
Income from Continuing Operations
Total Other Income/Expenses Net15,000  11,000  16,827  38,173  
Earnings Before Interest And Taxes776,000  462,000  773,224  668,776  
Interest Expense39,000  39,000  35,918  40,082  
Income Before Tax737,000  423,000  737,306  628,694  
Income Tax Expense277,000  84,000  147,884  (143,884)
Minority Interest -   -   -   -  
Net Income From Continuing Ops460,000  339,000  589,422  772,578  
Non-recurring Events
Discontinued Operations6,000  36,000  129  192,871  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 466,000   375,000   589,551   965,449  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 466,000   375,000   589,551   965,449  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.